Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Spence

Showing results (381-390 of 406) with videos related to

Pageof 41
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2004
18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matterAlexander M Spence, Mark Muzi, David A Mankoff, et al.
Investigational New Drugs|October 31, 2003
A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors consortium reportSusan M Chang, John G Kuhn, H Ian Robins, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2005
[F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failureJames G Douglas, Keith J Stelzer, David A Mankoff, et al.
Neuro-Oncology|April 17, 2001
A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: a North American Brain Tumor Consortium studyS C Schold, J G Kuhn, S M Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Apurinic endonuclease activity in adult gliomas and time to tumor progression after alkylating agent-based chemotherapy and after radiotherapyMichael S Bobola, Mary J Emond, A Blank, et al.
Cancer|April 2, 2011
A phase 1/2 study of orally administered synthetic hypericin for treatment of recurrent malignant gliomasWilliam T Couldwell, Amy A Surnock, Alfonso J Tobia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 7, 1998
Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constantA M Spence, M Muzi, M M Graham, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2002
Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalationKevin S Tralins, James G Douglas, Keith J Stelzer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
2-[(18)F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcomeAlexander M Spence, Mark Muzi, Michael M Graham, et al.
Nuclear Medicine and Biology|October 9, 2007
Challenges in clinical studies with multiple imaging probesKenneth A Krohn, Finbarr O'Sullivan, John Crowley, et al.
Pageof 41

Showing results (381-390 of 406) with videos related to

Sort By:
Pageof 41
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2004
18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matterAlexander M Spence, Mark Muzi, David A Mankoff, et al.
Investigational New Drugs|October 31, 2003
A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors consortium reportSusan M Chang, John G Kuhn, H Ian Robins, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2005
[F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failureJames G Douglas, Keith J Stelzer, David A Mankoff, et al.
Neuro-Oncology|April 17, 2001
A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: a North American Brain Tumor Consortium studyS C Schold, J G Kuhn, S M Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Apurinic endonuclease activity in adult gliomas and time to tumor progression after alkylating agent-based chemotherapy and after radiotherapyMichael S Bobola, Mary J Emond, A Blank, et al.
Cancer|April 2, 2011
A phase 1/2 study of orally administered synthetic hypericin for treatment of recurrent malignant gliomasWilliam T Couldwell, Amy A Surnock, Alfonso J Tobia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 7, 1998
Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constantA M Spence, M Muzi, M M Graham, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2002
Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalationKevin S Tralins, James G Douglas, Keith J Stelzer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
2-[(18)F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcomeAlexander M Spence, Mark Muzi, Michael M Graham, et al.
Nuclear Medicine and Biology|October 9, 2007
Challenges in clinical studies with multiple imaging probesKenneth A Krohn, Finbarr O'Sullivan, John Crowley, et al.
Pageof 41